EMI (Encore Medical) Inventories, Work In Process: $0.03 Mil (As of Dec. 2025)


What is Encore Medical Inventories, Work In Process?

Encore Medical EMI Inventories, Work In Process is $0.03 Mil as of Dec. 2025.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Encore Medical's work in process for the quarter that ended in Dec. 2025 was $0.03 Mil.

Encore Medical Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Encore Medical's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Inventories, Work In Process Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
Inventories, Work In Process
0.03 0.02 0.03

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Inventories, Work In Process Get a 7-Day Free Trial 0.00 0.02 0.05 0.09 0.03

Encore Medical Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of $0.03 Mil mean?
Encore Medical (EMI) has a Inventories, Work In Process of $0.03 Mil as of Dec. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Encore Medical and its competitors.
Is Encore Medical's Inventories, Work In Process too high?
Encore Medical's current Inventories, Work In Process is $0.03 Mil.
How does Encore Medical's Inventories, Work In Process compare to ?
Encore Medical's Inventories, Work In Process of $0.03 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Devices & Instruments company?
A good Inventories, Work In Process depends on the Medical Devices & Instruments industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Encore Medical and its competitors. Encore Medical's current Inventories, Work In Process is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current Inventories, Work In Process of $0.03 Mil. The current Inventories, Work In Process is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Encore Medical (EMI), the current Inventories, Work In Process is $0.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).